Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Journal of Clinical Oncology

Volumn 34, Issue 12, 2016, Pages 1297-1299

  Pahlman, Lars A ^a   Hohenberger, Werner M ^b   Matzel, Klaus ^b   Sugihara, Kenichi ^c   Quirke, Philip ^d   Glimelius, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; HUMAN; NOTE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CANCER; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; COLON RESECTION; COLONIC NEOPLASMS; DISEASE COURSE; DISEASE FREE SURVIVAL; MORTALITY; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84963595653     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.3048     Document Type: Note

References (29)

1. NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
2. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345:939-944, 1995
3. Moertel CG, Fleming TR, Macdonald JS, et al: Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13:2936-2943, 1995
4. André T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
5. Yothers G, O'Connell MJ, Allegra CJ, et al: Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29:3768-3774, 2011
6. Schmoll HJ, Tabernero J, Maroun J, et al: Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results of the NO16968 randomized controlled phase III trial. J Clin Oncol 33:3733-3740, 2015
7. Tournigand C, André T, Bonnetain F, et al: Adjuvant therapywith fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: Subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 30:3353-3360, 2012
8. Heald RJ, Moran BJ, Ryall RD, et al: Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133:894-899, 1998
9. Pahlman L, Bohe M, Cedermark B, et al: The Swedish rectal cancer registry. Br J Surg 94:1285-1292, 2007
10. GurenMG, Kørner H, Pfeffer F, et al: Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncol 54:1714-1722, 2015
11. Martling AL, Holm T, Rutqvist LE, et al: Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm: Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 356:93-96, 2000
12. Moriya Y, Hojo K, Sawada T, et al: Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32:307-315, 1989
13. Lange MM, Martz JE, Ramdeen B, et al: Long-term results of rectal cancer surgery with a systematical operative approach. Ann Surg Oncol 20:1806-1815, 2013
14. Hohenberger W, Weber K, Matzel K, et al: Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation-Technical notes and outcome. Colorectal Dis 11:354-364, discussion 364-365, 2009
15. West NP, Kobayashi H, Takahashi K, et al: Understanding optimal colonic cancer surgery: Comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30: 1763-1769, 2012
16. Bertelsen CA, Neuenschwander AU, Jansen JE, et al; Danish Colorectal Cancer Group: Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: A retrospective, population-based study. Lancet Oncol 16:161-168, 2015
17. Kotake K, Mizuguchi T, Moritani K, et al: Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 29: 847-852, 2014
18. Shimada Y, Hamaguchi T, Mizusawa J, et al: Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205. Eur J Cancer 50:2231-2240, 2014
19. Bernhoff R, Martling A, Sjö vall A, et al: Improved survival after an educational project on colon cancer management in the county of Stockholm: A population based cohort study. Eur J Surg Oncol 41:1479-1484, 2015
20. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291-1304, 2001
21. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al; Dutch Colorectal Cancer Group: Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. N Engl J Med 345: 638-646, 2001
22. Sebag-Montefiore D, Stephens RJ, Steele R, et al: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
23. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987, 1997
24. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
25. Sauer R, Liersch T, Merkel S, et al: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933, 2012
26. Bö ckelman C, Engelmann BE, Kaprio T, et al: Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 54:5-16, 2015
27. Figueredo A, Coombes ME, Mukherjee S: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 3: CD005390, 2008
28. Gill S, Loprinzi CL, Sargent DJ, et al: Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 22:1797-1806, 2004
29. Mols F, Beijers T, Lemmens V, et al: Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: Results from the population-based PROFILES registry. J Clin Oncol 31: 2699-2707, 2013